Trial Profile
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- Sponsors Medifarma
- 13 Mar 2023 Status changed from active, no longer recruiting to completed.
- 06 Aug 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Dec 2019.
- 04 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.